产地 | 进口、国产 |
品牌 | 上海莼试 |
保存条件 | Store at -20 °C |
货号 | CS12270 |
应用范围 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
CAS编号 | |
抗体名 | Anti-SRRM1 |
克隆性 | 是 |
靶点 | 详见说明书 |
适应物种 | 详见说明书 |
形态 | 详见说明书 |
宿主 | 详见说明书 |
亚型 | IgG |
标识物 | 详见说明书 |
浓度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human SRRM1 |
产品订购信息:
英文名称 Anti-SRRM1
中文名称 丝氨酸/精氨酸相关核基质蛋白1抗体规格
别 名 Ser/Arg related nuclear matrix protein; Ser/Arg-related nuclear matrix protein; Serine/arginine repetitive matrix protein 1; SR related nuclear matrix protein of 160 kDa; SR-related nuclear matrix protein of 160 kDa; SRm160; Srrm1; SRRM1_HUMAN.
浓 度 1mg/1ml
规 格 0.2ml/200μg
抗体来源 Rabbit
克隆类型 polyclonal
交叉反应 Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit
产品类型 一抗
研究领域 细胞生物 染色质和核信号 表观遗传学
蛋白分子量 predicted molecular weight: 102kDa
性 状 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human SRRM1
亚 型 IgG
纯化方法 affinity purified by Protein A
储 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
丝氨酸/精氨酸相关核基质蛋白1抗体规格 产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蜡切片需做抗原修复)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
产品介绍 Part of pre- and post-splicing multiprotein mRNP complexes. Involved in numerous pre-mRNA processing events. Promotes constitutive and exonic splicing enhancer (ESE)-dependent splicing activation by bridging together sequence-specific (SR family proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP (SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA 3'-end cleavage independently of the formation of an exon junction complex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream of exon-exon junctions. Binds RNA and DNA with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates.
Function : Part of pre- and post-splicing multiprotein mRNPcomplexes. Involved in numerous pre-mRNA processing events.Promotes constitutive and exonic splicing enhancer (ESE)-dependentsplicing activation by bridging together sequence-specific (SRfamily proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP(SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA3'-end cleavage independently of the formation of an exon junctioncomplex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream ofexon-exon junctions. Binds RNA and DNA with low sequencespecificity and has similar preference for either double- orsingle-stranded nucleic acid substrates.
Subunit : Identified in the spliceosome C complex. Found in apre-mRNA splicing complex with SFRS4, SFRS5, SNRP70, SNRPA1, SRRM1and SRRM2. Found in a pre-mRNA exonic splicing enhancer (ESE)complex with SNRP70, SNRPA1, SRRM1 and TRA2B/SFRS10. Found in amRNA splicing-dependent exon junction complex (EJC) with DEK,PRPF8, NCBP1, RBM8A, RNPS1, SRRM1 and ALYREF/THOC4. Interacts withBAT1, CPSF1, RBM8A, RNPS1, and ALYREF/THOC4. Seems to be a compoundof RNA export complexes that are released from speckles in aATP-dependent manner.
Subcellular Location : Nucleus matrix. Nucleus speckle.
Similarity : Belongs to the splicing factor SR family.
Contains 1 PWI domain.
Database links : UniProtKB/Swiss-Prot: Q8IYB3.2
转录辅助因子退变样蛋白4 多克隆抗体 VGLL4 Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
溶质载体家族17(依赖无机磷酸协同转运蛋白)成员6 多克隆抗体 VGLU2 Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
vonHippel-Lindau抑制因子 多克隆抗体 VHL Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
极受体 多克隆抗体 VLDLR Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
波形蛋白IF关联卷曲螺旋蛋白 多克隆抗体 VMAC Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
自噬相关蛋白12抗体 孕激素受体抗体
自噬相关蛋白13抗体 孕激素受体β(MPRβ)抗体
自噬相关蛋白3抗体 阅读障碍相关蛋白DLX2抗体
G1氨基A型受体相似蛋白2抗体 远端上游元件结合蛋白3抗体
整合素样金属蛋白酶与凝血酶4型抗体 原纤维蛋白2抗体
新朊蛋白抗体 CWF19L1蛋白抗体
SHISA蛋白家族9抗体 CWC22蛋白抗体
固醇携带蛋白2抗体 CUTL1蛋白抗体
唾液酸结合性免疫球蛋白样凝集素1抗体 CULLIN抗体
SPOP蛋白抗体 Cullin3抗体
棉籽Cotton seed Raffinose 棉子糖 512-69-6 C18H32O16 ≥98%
川陈皮速NobilqtinHPLC≥98%;20mg/支
7-去甲基银杏双黄同;7-去甲基银杏双黄同;果素 7-去甲基银杏双黄同 Bilobetin 521-32-4 20mg HPLC≥98% 用于含量测定
中药对照药材雄蚕蛾(家蚕)121457-200501TLC法鉴别
Ginkgolic Acid (C15:1)银杏酸(C15:1)纯度:≥99%
丝氨酸/精氨酸相关核基质蛋白1抗体规格云南红豆杉Taxus yunnanensis Taxiresinol 紫杉脂素 40951-69-7 C19H22O6 ≥97%
月桂氮卓同Lcuroccprcm297-89-30.1ml
芦荟苷;芦荟甙;芦荟大黄素甙;芦荟素 Aloin 1415-73-2 20mg HPLC≥98% 用于含量测定
对照品他唑巴坦130511-200402含量测定
大花双参苷A iplostoside A 20mg HPLC≥98% 大花双参苷A用于含量测定
抗体的生物素化标记实验要点:
1. 丝氨酸/精氨酸相关核基质蛋白1抗体规格 如在反应混合液中有叠氮钠或游离氨基存在,会抑制标记反应。因此,蛋白质在反应前要对 0.1mol/L碳酸氢钠缓冲液或0.5mol/L硼酸缓冲液充分透析;
2.所用的NHSB及待生物素化蛋白质之间的分子比按蛋白质表面的ε-氨基的密度会有所不同,选择不当则影响标记的效率,应先用几个不同的分子比来筛选最适条件;
3.用NHSB量过量也是不利的,抗原的结合位点可能因此被封闭,导致抗体失活;
4.由于抗体的氨基不易接近可能造成生物素化不足,此时可加入去污剂如 Triton x-100, Tween20等;
5.当游离ε-氨基(赖氨酸残基的氨基)存在于抗体的抗原结合位点时,或位于酶的催化位点时,生物素化会降低或损伤抗体蛋白的结合力或活性;
6.生物素还可能与不同的功能基团,如羰基、氨基、巯基、异咪唑基及苯酚基,也可与糖基共价结合;
7.交联反应后,应充分透析,否则,残余的生物素会对生物素化抗体与亲和素的结合产生竞争作用;
8.在细胞的荧光标记实验中,中和亲和素的本底低,但由于链霉亲和素含有少量正电荷,故对某些细胞可导致高本底。
抗体的鉴定:
1)丝氨酸/精氨酸相关核基质蛋白1抗体规格 抗体的效价鉴定:不管是用于诊断还是用于,制备抗体的目的都是要求较高效价。不同的抗原制备的抗体,要求的效价不一。鉴定效价的方法很多,包括有试管凝集反应,琼脂扩散试验,酶联免疫吸附试验等。常用的抗原所制备的抗体一般都有约成的鉴定效价的方法,以资比较。如制备抗抗体的效价,一般就采用琼脂扩散试验来鉴定。
2)抗体的特异性鉴定:抗体的特异性是指与相应抗原或近似抗原物质的识别能力。抗体的特异性高,它的识别能力就强。衡量特异性通常以交叉反应率来表示。交叉反应率可用竞争抑制试验测定。以不同浓度抗原和近似抗原分别做竞争抑制曲线,计算各自的结合率,求出各自在IC50时的浓度,并按公式计算交叉反应率。
如果所用抗原浓度IC50浓度为pg/管,而一些近似抗原物质的IC50浓度几乎是无穷大时,表示这一抗血清与其他抗原物质的交叉反应率近似为0,即该血清的特异性较好。
3)抗体亲和力:是指抗体和抗原结合的牢固程度。亲和力的高低是由抗原分子的大小,抗体分子的结合位点与抗原决定簇之间立体构型的合适度决定的。有助于维持抗原抗体复合物稳定的分子间力有氢键,疏水键,侧链相反电荷基因的库仑力,范德华力和空间斥力。亲和力常以亲和常数K表示,K的单位是L/mol。抗体亲和力的测定对抗体的筛选,确定抗体的用途,验证抗体的均一性等均有重要意义。